Literature DB >> 34027801

Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel Type 2 in 82 Eyes.

Kerul Marsonia1, Kedarisetti Kiran Chandra1, M Hasnat Ali2, Jay Chhablani3, Raja Narayanan1,2.   

Abstract

PURPOSE: : To evaluate the long-term natural course of macular telangiectasia Type 2, correlation with visual acuity and the incidence of Choroidal Neovascularisation (CNV) in Indian eyes.
MATERIAL AND METHODS: : A Retrospective analysis of Patients with MacTel Type 2 was done over a period of 12 years with all patients having a minimum of 3 years follow up. The demographic details and ocular characteristics including best-corrected visual acuity (BCVA), fundus photography, fluorescein angiography, and optical coherence tomography images were studied in both proliferative and non-proliferative MacTel. Mixed models were used to estimate progression rates and a Kaplan Meier estimation of BCVA was plotted.
RESULTS: : Eighty-two eyes of 47 patients were studied over a period of mean duration of 4.5 years (range: 3 years-8.5 years). There was no difference in the demographic characteristics between the non-proliferative MacTel and proliferative MacTel groups. There were no significant risk factors observed for progression. However, patients with retinal greying had significant risk reduction for a BCVA decline. The mean logMAR BCVA decreased from 0.25 ± 0.25 at baseline to 0.46 ± 0.42 by 4 years. Twenty-eight percent of the patients maintained their vision 8 years from baseline and were unlikely to progress. The incidence of CNV was 10.6% and the mean duration for the development of CNV was 2.36 years from baseline. Seventy-Three percent (11 of 15) patients with CNV had a BCVA of <20/40.
CONCLUSION: : In patients of MacTel, the maximum vision loss occurred at the fourth year and then stabilized. The major cause of poor vision observed was CNV (active in 10.98% and scarred in 7.32%), foveal atrophy (10.98%) and central pigmented plaques (3.66%). The incidence of sight-threatening complication of CNV (10.6%) is likely to occur only in a minority of eyes.

Entities:  

Keywords:  Disease progression; Indian eyes; MacTel type 2; Natural history; Visual acuity; choroidal Neovascularization; neovascularization

Mesh:

Year:  2021        PMID: 34027801      PMCID: PMC7612874          DOI: 10.1080/08820538.2021.1929347

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   2.246


  12 in total

1.  Evolution and management of macular hole secondary to type 2 idiopathic macular telangiectasia.

Authors:  D Shukla
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

2.  CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.

Authors:  Tunde Peto; Tjebo F C Heeren; Traci E Clemons; Ferenc B Sallo; Irene Leung; Emily Y Chew; Alan C Bird
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

3.  Long-term juxtafoveal retinal telangiectasia.

Authors:  Robert C Watzke; Michael L Klein; James C Folk; Samuel G Farmer; Richard S Munsen; Robert J Champfer; K R Sletten
Journal:  Retina       Date:  2005-09       Impact factor: 4.256

4.  SEX STEROIDS AND MACULAR TELANGIECTASIA TYPE 2.

Authors:  Simone Müller; Jean-Pierre Allam; Christopher G Bunzek; Traci E Clemons; Frank G Holz; Peter Charbel Issa
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

5.  Idiopathic macular telangiectasia.

Authors:  Lawrence A Yannuzzi; Anne M C Bardal; K Bailey Freund; Kuan-Jen Chen; Chiara M Eandi; Barbara Blodi
Journal:  Arch Ophthalmol       Date:  2006-04

6.  Long-term course in type 2 idiopathic macular telangiectasia.

Authors:  Tobias Meyer-ter-Vehn; Sina Herzog; Marc Schargus; Winfried Göbel; Rainer Guthoff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-25       Impact factor: 3.117

7.  Idiopathic juxtafoveolar retinal telangiectasis.

Authors:  J D Gass; R T Oyakawa
Journal:  Arch Ophthalmol       Date:  1982-05

8.  Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

Authors:  J D Gass; B A Blodi
Journal:  Ophthalmology       Date:  1993-10       Impact factor: 12.079

9.  Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3.

Authors:  Traci E Clemons; Mark C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Jie Jin Wang; Paul Mitchell; Wishal D Ramdas; Johannes R Vingerling
Journal:  Ophthalmic Epidemiol       Date:  2013-04       Impact factor: 1.648

10.  Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.

Authors:  Traci E Clemons; Marc C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Maria J Figueroa; Molly W Harrington
Journal:  Ophthalmic Epidemiol       Date:  2010 Jan-Feb       Impact factor: 1.648

View more
  2 in total

1.  Characteristics of retinal pigment clumps in Type 2 macular telangiectasia (MacTel).

Authors:  Ramesh Venkatesh; Sameeksha Agrawal; Nikitha Gurram Reddy; Pranjal Mishra; Deepashri Mutalik; Naresh Kumar Yadav; Jay Chhablani
Journal:  Eye (Lond)       Date:  2022-04-14       Impact factor: 3.775

Review 2.  Macular Telangiectasia Type 2: A Comprehensive Review.

Authors:  Kiran Chandra Kedarisetti; Raja Narayanan; Michael W Stewart; Nikitha Reddy Gurram; Arshad M Khanani
Journal:  Clin Ophthalmol       Date:  2022-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.